Xenon Pharmaceuticals Inc. ( XENE) - Stock Earnings
XENE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -105.3 million USD | — USD |
| 2026Q1 | -102.3 million USD | — USD |
| 2026Q2 | -110.7 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
XENE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -182.4 million USD | — USD |
| 2024 | -234.3 million USD | — USD |
| 2025 | -345.9 million USD | 7.5 million USD |
| 2026 Est. | — | — |
XENE
Price: $38.02
52 week price:
Earnings Per Share: -4.63 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 730900
Ebitda: -8.5 millionMarket Capitalization: 5.8 billion